Top compounds associated with response to TIGD7


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.073 0.06
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.072 0.06
mRNA PF-4708671 GDSC1000 pan-cancer AAC -0.067 0.06
mRNA canertinib CTRPv2 pan-cancer AAC -0.071 0.06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.06
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.059 0.06
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.06
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.069 0.06
mRNA L-685458 CTRPv2 pan-cancer AAC -0.073 0.07
mRNA KPT185 CTRPv2 pan-cancer AAC 0.075 0.07
Download CSV